<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) is known as a causative agent of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> and approximately 10% of stomach <z:mp ids='MP_0002038'>carcinoma</z:mp> cases </plain></SENT>
<SENT sid="1" pm="."><plain>In other human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, EBV gene expression including lytic <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> protein detected using in situ hybridization and immunofluorescence staining has been reported </plain></SENT>
<SENT sid="2" pm="."><plain>Moreover, the expression and replication of EBV genes in cultured <z:mpath ids='MPATH_458'>normal</z:mpath> macrophages and in histiocytes of Langerhans' cell <z:mpath ids='MPATH_146,MPATH_652'>histiocytosis</z:mpath> have been identified </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this study was to examine EBV expression in macrophages in other EBV-associated human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Forty-one cases of EBV-associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, which had been confirmed to express EBV, were examined </plain></SENT>
<SENT sid="5" pm="."><plain>Tissue sections after in situ hybridization were double-stained immunohistochemically with the monoclonal anti-CD68 antibody </plain></SENT>
<SENT sid="6" pm="."><plain>EBV expression in macrophages in the lesions of nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp>, <z:e sem="disease" ids="C0153381" disease_type="Neoplastic Process" abbrv="">oral cancer</z:e>, <z:hpo ids='HP_0002890'>thyroid carcinoma</z:hpo>, <z:hpo ids='HP_0005584'>renal cell carcinoma</z:hpo>, testicular <z:mp ids='MP_0002038'>carcinoma</z:mp>, uterine <z:mp ids='MP_0002038'>carcinoma</z:mp>, cutaneous T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and anaplastic large-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> was identified, whereas macrophages in <z:mpath ids='MPATH_458'>normal</z:mpath> or non-cancerous lesions showed no EBV expression </plain></SENT>
<SENT sid="7" pm="."><plain>Many <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-associated macrophages in EBV-related <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> carry EBV, which appears to induce the EBV lytic <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> of macrophages </plain></SENT>
<SENT sid="8" pm="."><plain>Therefore, the possibility that the lytic <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> of macrophages by EBV and the resulting <z:mp ids='MP_0001845'>inflammation</z:mp> play certain roles in the <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> of EBV-associated human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> was raised </plain></SENT>
</text></document>